| Literature DB >> 16928275 |
Abstract
AIM: International collaboration for health system development has been identified as a critical input to meet pressing global health needs. North-South collaboration has the potential to benefit both parties, while South-South collaboration offers promise to strengthen capacity rapidly and efficiently across developing countries. There is an emerging trend to analyze the fruits of such collaboration. This paper builds on this trend by applying an innovative concept-based bibliometric method to identify the international scope of collaboration within the field of health policy and systems research. Two key questions are addressed: to what extent are papers comparing developing countries as against reporting on single country studies? To what extent are papers in either case being produced by researchers within their respective countries or through North-South or South-South collaboration?Entities:
Year: 2006 PMID: 16928275 PMCID: PMC1569829 DOI: 10.1186/1478-4505-4-7
Source DB: PubMed Journal: Health Res Policy Syst ISSN: 1478-4505
Figure 1Medline MeSH Terms Used for the Primary Selection.
Figure 2Health systems papers for developing countries, by topic.
Citations and hits obtained with different bibliometric procedures, Medline, 1991–2003.
| 0–100% | 36,794 | 24,629 | 25,894 | 87,317 | |
| 11%–100% | 8,039 | 2,467 | 5,729 | 16,235 | |
| 11%–100% | 7,762 | 2,424 | 5,566 | 15,671 | |
*As classified by the Collexis search engine. Relevance above 11% is considered acceptable for the purposes of this study.
** Topic specific hits could overlap across topics. The following row eliminates such duplications.
Health policy and systems research papers by topic, and percentage included in the sample, Medline 1999–2003.
| Accessibility | 365 | 11 | 41 |
| Community participation | 1,359 | 6 | 76 |
| Cost and cost effectiveness | 1,653 | 6 | 92 |
| Decentralization | 242 | 22 | 54 |
| Economic and social policy and health | 244 | 22 | 54 |
| Equity | 944 | 6 | 53 |
| Finance | 632 | 11 | 71 |
| Human resources | 675 | 11 | 75 |
| Information systems | 593 | 11 | 66 |
| Information, Education and Communication | 2,339 | 6 | 131 |
| Insurance | 385 | 11 | 43 |
| Organization and delivery | 1,178 | 6 | 66 |
| Pharmaceutical policy and management | 1,015 | 6 | 57 |
| Policy process | 1,533 | 6 | 86 |
| Program evaluation | 1,098 | 6 | 61 |
| Quality of care | 616 | 11 | 69 |
| Research Policy and process | 118 | 34 | 40 |
| Sector analysis | 1,246 | 6 | 70 |
| 7 | |||
Coverage of papers in health policy and systems according to the income region of the corresponding author's institution.
| 127 | 49 | 18 | 69 | 164 | 99 | 7 | 2 | |||||
| 50 | 19 | 3 | 12 | 93 | 96 | 1 | 0 | |||||
| 74 | 29 | 5 | 19 | 1 | 1 | 267 | 95 | |||||
| 6 | 2 | 1 | 1 | 4 | 4 | 7 | 2 | |||||
Country coverage of single-country papers in health systems according to the nationality and income region of the corresponding author's institution.
| - | - | - | - | 153 | 94 | 21 | ||||||||
| - | - | - | - | 90 | 98 | 12 | ||||||||
| - | - | - | - | 247 | 90 | 33 | ||||||||
| 99 | 51 | 14 | 64 | 9 | 6 | 6 | 2 | 17 | ||||||
| 43 | 22 | 3 | 14 | 2 | 2 | 1 | 0 | 7 | ||||||
| 53 | 27 | 5 | 23 | 19 | 7 | 10 | ||||||||
| 195 | 100 | 22 | 100 | 162 | 100 | 92 | 100 | 273 | 100 | 744 | 100 | 100 | ||
Countries covered by multiple-country health policy and systems papers, according to the nationality and income region of the lead author's institution.
| 11 | 18 | - | - | 2 | 50 | |||||||||
| 3 | 5 | - | - | 1 | 20 | |||||||||
| 17 | 27 | - | - | 1 | 25 | 1 | 11 | |||||||
| 1 | 2 | - | - | 1 | 25 | 4 | 80 | 6 | 67 | |||||
| 17 | 27 | 4 | 100 | 1 | 11 | |||||||||
| 4 | 6 | |||||||||||||
| 4 | 6 | |||||||||||||
| 5 | 8 | 1 | 11 | |||||||||||
Health systems papers by country of corresponding author institution. Developing Countries, Medline 1991–2003*.
| No. | % | No. | % | No. | % | No. | % | ||||
| India | 52 | 31 | China | 46 | 48 | Brazil | 93 | 33 | USA | 121 | 47 |
| Nigeria | 24 | 14 | Thailand | 19 | 20 | South Africa | 62 | 22 | United Kingdom | 54 | 21 |
| Kenya | 16 | 9.6 | Colombia | 6 | 6.3 | Mexico | 31 | 11 | Sweden | 13 | 5.1 |
| Ethiopia | 10 | 6.0 | Papua New Guinea | 5 | 5.2 | Korea | 17 | 6.0 | Australia | 12 | 4.7 |
| Pakistan | 9 | 5.4 | Philippines | 4 | 4.2 | Turkey | 15 | 5.3 | Canada | 8 | 3.1 |
| Vietnam | 9 | 5.4 | Tunisia | 3 | 3.1 | Mexico | 12 | 4.3 | France | 8 | 3.1 |
| Bangladesh | 8 | 4.8 | Cuba | 2 | 2.1 | Chile | 9 | 3.2 | Germany | 7 | 2.7 |
| Uganda | 8 | 4.8 | Egypt | 2 | 2.1 | Saudi Arabia | 9 | 3.2 | Italy | 6 | 2.3 |
| Tanzania | 7 | 4.2 | Jamaica | 2 | 2.1 | Argentina | 7 | 2.5 | Netherlands | 5 | 1.9 |
| Zimbabwe | 5 | 3.0 | Kazakhstan | 2 | 2.1 | Malaysia | 7 | 2.5 | Switzerland | 5 | 1.9 |
| Ghana | 2 | 1.2 | Peru | 2 | 2.1 | Puerto Rico | 7 | 2.5 | Japan | 4 | 1.6 |
| Indonesia | 2 | 1.2 | Iran | 1 | 1.0 | Oman | 3 | 1.1 | Belgium | 3 | 1.2 |
| Burkina Faso | 1 | 0.6 | Jordan | 1 | 1.0 | Lebanon | 2 | 0.7 | Portugal | 3 | 1.2 |
| Guinea-Bissau | 1 | 0.6 | Malaysia | 1 | 1.0 | Bahrain | 1 | 0.4 | Denmark | 2 | 0.8 |
| Honduras | 1 | 0.6 | Botswana | 1 | 0.4 | Norway | 2 | 0.8 | |||
| Lesotho | 1 | 0.6 | Croatia | 1 | 0.4 | Finland | 1 | 0.4 | |||
| Madagascar | 1 | 0.6 | Israel | 1 | 0.4 | Ireland | 1 | 0.4 | |||
| Mali | 1 | 0.6 | Panama | 1 | 0.4 | New Zealand | 1 | 0.4 | |||
| Mozambique | 1 | 0.6 | Trinidad and Tobago | 1 | 0.4 | Spain | 1 | 0.4 | |||
| Myanmar | 1 | 0.6 | Uruguay | 1 | 0.4 | ||||||
| Nicaragua | 1 | 0.6 | Venezuela | 1 | 0.4 | ||||||
| Niger | 1 | 0.6 | |||||||||
| North | 1 | 0.6 | |||||||||
| Senegal | 1 | 0.6 | |||||||||
| Uzbekistan | 1 | 0.6 | |||||||||
| Zambia | 1 | 0.6 | |||||||||
| TOTAL | 166 | 100 | 96 | 100 | 282 | 100 | 257 | 100 | |||
| Total Countries | 26 | 16 | 14 | 21 | 19 | ||||||
*28 International agencies are excluded in this table
Number of countries covered by papers.
| 195 | 76 | 22 | 85 | 162 | 98 | 93 | 96 | 273 | 97 | |||
| 41 | 16 | 3 | 12 | 3 | 2 | 4 | 4 | 7 | 2 | |||
| 21 | 8 | 1 | 4 | 1 | 1 | 2 | 1 | |||||
Countries studied in papers including at least one developing country. Medline 1999–2003.
| India | 148 | 23.1 | China | 81 | 37.7 | Brazil | 134 | 27.3 | USA | 52 | 52.5 | |
| Nigeria | 47 | 7.3 | Thailand | 32 | 14.9 | South Africa | 110 | 22.4 | Great Britain | 15 | 15.2 | |
| Tanzania | 43 | 6.7 | Philippines | 13 | 6.0 | Mexico | 84 | 17.1 | Canada | 7 | 7.1 | |
| Vietnam | 40 | 6.2 | Colombia | 11 | 5.1 | Korea | 28 | 5.7 | Japan | 6 | 6.1 | |
| Kenya | 38 | 5.9 | Egypt | 11 | 5.1 | Turkey | 28 | 5.7 | Netherlands | 6 | 6.1 | |
| Bangladesh | 36 | 5.6 | Guatemala | 9 | 4.2 | Chile | 25 | 5.1 | England | 2 | 2.0 | |
| Uganda | 26 | 4.0 | Papua New Guinea | 9 | 4.2 | Puerto Rico | 19 | 3.9 | France | 2 | 2.0 | |
| Pakistan | 23 | 3.6 | Morocco | 7 | 3.3 | Argentina | 13 | 2.7 | Germany | 2 | 2.0 | |
| Zimbabwe | 23 | 3.6 | Peru | 7 | 3.3 | Malaysia | 13 | 2.7 | Italy | 2 | 2.0 | |
| Ghana | 19 | 3.0 | Tunisia | 7 | 3.3 | Saudi Arabia | 10 | 2.0 | New Zealand | 2 | 2.0 | |
| Zambia | 18 | 2.8 | Jordan | 5 | 2.3 | Botswana | 4 | 0.8 | Switzerland | 2 | 2.0 | |
| Indonesia | 17 | 2.6 | Dominican Republic | 4 | 1.9 | Lebanon | 4 | 0.8 | Sweden | 1 | 1.0 | |
| Nepal | 17 | 2.6 | Cuba | 3 | 1.4 | Venezuela | 4 | 0.8 | ||||
| Burkina Faso | 14 | 2.2 | Jamaica | 3 | 1.4 | Panama | 3 | 0.6 | ||||
| Ethiopia | 14 | 2.2 | Kazakhstan | 3 | 1.4 | Georgia | 2 | 0.4 | ||||
| Rwanda | 10 | 1.6 | El Salvador | 2 | 0.9 | Oman | 2 | 0.4 | ||||
| Mali | 8 | 1.2 | Iran | 2 | 0.9 | Bahrain | 1 | 0.2 | ||||
| Nicaragua | 8 | 1.2 | Belize | 1 | 0.5 | Gabon | 1 | 0.2 | ||||
| Senegal | 8 | 1.2 | Brazil | 1 | 0.5 | Iraq | 1 | 0.2 | ||||
| Benin | 7 | 1.1 | Cambodia | 1 | 0.5 | Morocco | 1 | 0.2 | ||||
| Mozambique | 7 | 1.1 | Costa Rica | 1 | 0.5 | Trinidad and Tobago | 1 | 0.2 | ||||
| Cameroon | 6 | 0.9 | Ecuador | 1 | 0.5 | Uruguay | 1 | 0.2 | ||||
| Cote d'Ivoire | 6 | 0.9 | Namibia | 1 | 0.5 | Uzbekistan | 1 | 0.2 | ||||
| Haiti | 6 | 0.9 | ||||||||||
| Niger | 6 | 0.9 | ||||||||||
| Malawi | 5 | 0.8 | ||||||||||
| Cambodia | 4 | 0.6 | ||||||||||
| Burundi | 3 | 0.5 | ||||||||||
| Chad | 3 | 0.5 | ||||||||||
| Gambia | 3 | 0.5 | ||||||||||
| Myanmar | 3 | 0.5 | ||||||||||
| Sri Lanka | 3 | 0.5 | ||||||||||
| Afghanistan | 2 | 0.3 | ||||||||||
| Congo | 2 | 0.3 | ||||||||||
| Honduras | 2 | 0.3 | ||||||||||
| Lesotho | 2 | 0.3 | ||||||||||
| Madagascar | 2 | 0.3 | ||||||||||
| Sudan | 2 | 0.3 | ||||||||||
| Swaziland | 2 | 0.3 | ||||||||||
| Bhutan | 1 | 0.2 | ||||||||||
| Central African Republic | 1 | 0.2 | ||||||||||
| Democratic Republic of the Congo | 1 | 0.2 | ||||||||||
| Guinea-Bissau | 1 | 0.2 | ||||||||||
| Kyrgyzstan | 1 | 0.2 | ||||||||||
| Laos | 1 | 0.2 | ||||||||||
| Liberia | 1 | 0.2 | ||||||||||
| Somalia | 1 | 0.2 | ||||||||||
| Togo | 1 | 0.2 | ||||||||||
Country coverage of health systems papers by topic. Medline 1991–2003*.
| Financing | 262 | 74 | 91 | 26 | 353 | 100 |
| Research policy and process | 54 | 82 | 12 | 18 | 66 | 100 |
| Human resources | 313 | 83 | 64 | 17 | 377 | 100 |
| Equity | 453 | 86 | 74 | 14 | 527 | 100 |
| Information, Education and Communication | 1,125 | 86 | 181 | 14 | 1,306 | 100 |
| Policy process | 741 | 87 | 115 | 13 | 856 | 100 |
| Insurance | 187 | 87 | 28 | 13 | 215 | 100 |
| Economic and social policy and health | 121 | 89 | 15 | 11 | 136 | 100 |
| Sector analysis | 625 | 90 | 71 | 10 | 696 | 100 |
| Accessibility | 185 | 90 | 19 | 10 | 204 | 100 |
| Information systems | 300 | 91 | 31 | 9 | 331 | 100 |
| Descentralization | 123 | 91 | 13 | 9 | 135 | 100 |
| Quality of care | 313 | 91 | 31 | 9 | 344 | 100 |
| Pharmaceutical policy and management | 516 | 91 | 51 | 9 | 567 | 100 |
| Organization and delivery | 607 | 92 | 51 | 8 | 658 | 100 |
| Program evaluation | 573 | 94 | 40 | 6 | 613 | 100 |
| Cost and cost effectiveness | 884 | 96 | 39 | 4 | 923 | 100 |
| Community participation | 740 | 97 | 19 | 3 | 759 | 100 |
Health systems papers by income region or international agency origin of corresponding author and by topic medline 1991–2003*.
| Accessibility | 63 | 31 | 10 | 5 | 131 | 64 | 204 | 100 |
| Community participation | 190 | 25 | 27 | 4 | 542 | 71 | 759 | 100 |
| Cost and cost effectiveness | 346 | 38 | 69 | 8 | 508 | 55 | 923 | 100 |
| Descentralization | 42 | 31 | 3 | 2 | 90 | 67 | 135 | 100 |
| Economic and social policy and health | 38 | 28 | - | - | 98 | 72 | 136 | 100 |
| Equity | 169 | 32 | 21 | 4 | 337 | 64 | 527 | 100 |
| Finance | 158 | 45 | 9 | 3 | 186 | 53 | 353 | 100 |
| Human resources | 105 | 28 | 7 | 2 | 265 | 70 | 377 | 100 |
| Information systems | 81 | 25 | 12 | 4 | 238 | 72 | 331 | 100 |
| Information, Education and Communication | 435 | 33 | 17 | 1 | 853 | 65 | 1,306 | 100 |
| Insurance | 115 | 54 | 5 | 2 | 94 | 44 | 215 | 100 |
| Organization and delivery | 212 | 32 | 24 | 4 | 423 | 64 | 658 | 100 |
| Pharmaceutical policy and management | 145 | 25 | 11 | 2 | 411 | 73 | 567 | 100 |
| Policy process | 180 | 21 | 68 | 8 | 608 | 71 | 856 | 100 |
| Program evaluation | 134 | 22 | 22 | 4 | 457 | 75 | 613 | 100 |
| Quality of care | 76 | 22 | - | - | 268 | 78 | 344 | 100 |
| Research Policy and process | 17 | 25 | - | - | 50 | 75 | 66 | 100 |
| Sector analysis | 316 | 45 | 47 | 7 | 332 | 48 | 696 | 100 |
* Projected on the basis of a sample of 13% of all papers that were content analyzed.